Home » 論文ナビSCOPE » キーワード分析 » 【論文データ】S-1（自殖第一代）の国内研究動向まとめ 【論文データ】S-1（自殖第一代）の国内研究動向まとめ 論文ナビは研究者によって運営される論文解説プラットフォームです。このページでは、最近二年間(2016-2017)で発表された文献データを独自に収集・集計して分かりやすくまとめました。論文キーワードマップ、代表的な研究機関、頻出キーワード、分野のシェア、分野関連図、関連文献等により、今までない情報を提供します。 統計データ S-1chemotherapyTAS-102gastric cancercolorectal cancergemcitabineadjuvant chemotherapypancreatic canceroxaliplatinchemoradiotherapycisplatinnon-small-cell lung cancer (NSCLC)metastatic colorectal canceririnotecandihydropyrimidine dehydrogenaseneoadjuvant chemotherapyphase II studytrifluridinebevacizumabrectal cancerlung cancernab-paclitaxelcarboplatinpaclitaxelphase I studybiomarkeradjuvant therapypredictive factorthymidylate synthasebreast cancerbiliary tract cancerprognosiselderlydocetaxelperitoneal metastasisUFTneutropeniasecond line chemotherapyefficacyelderly patientscornearadiotherapypreoperative chemotherapyepidermal growth factor receptor (EGFR)panitumumabinduction chemotherapypancreatic ductal adenocarcinomaEQ-5Drandomized controlled trial5-fluorouracilfatty liverpharmacokineticsmaintenance therapysubgroup analysiswarfarinesophageal cancercetuximabinterstitial lung diseaseadverse eventsphase III studyalbuminRNA interference (RNAi)epidermal growth factorpeptide vaccineimmunotherapydermatomyositisimmunohistochemistryerlotinibIRISUGT1A1SN-38prospective studyfluorouracildistant metastasisCRTchemopreventionCDDPphosphorylationliver metastasishead and neck canceradult T-cell leukemia-lymphomaHTLV-1mRNAextramammary Paget's diseasecombinationprognostic factortaxanehealth-related quality of lifeQALYcost-effectivenessDNA repairATMtransporterretrospective studyconversion surgerypathological complete responsesurgeryneuroendocrine carcinomahepatocellular carcinoma (HCC)advanced gastric cancercapecitabinepredictive biomarkerprognostic markerpharmacogenomicsrecurrencesquamous cell carcinoma (SCC)oral squamous cell carcinomasurvival ratecolon cancersafetypopulation pharmacokineticscreatinine clearancerenal functionpostoperative complicationsnon-alcoholic fatty liver disease (NAFLD)pancreaticoduodenectomylocal recurrencethymidine phosphorylaseHER2-negativesmall cell lung cancer (SCLC)randomized trialamrubicinacute exacerbationclinical trialregorafenibnintedanibdrug interactioncolorectal liver metastasesBRAFK rassupportive carequality-of-life (QOL)resistancepemetrexedctDNAgefitinibthymic carcinomacombination therapyactivityanti-tumortumor microenvironmentliposomeEPR effectinductionanticancer drugcomplicationdefinitive chemoradiotherapynedaplatin
